concluded U.S. Supreme Court
U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine
Summary
By eliminating necessary safeguards for pregnant girls and women who undergo the dangerous mifepristone abortion drug regimen, the U.S. Food and Drug Administration failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women.
Press Releases
February 22, 2024
FDA endangered women’s health by removing key safeguards for high-risk abortion drugs
January 12, 2024
District court grants states’ request to hold FDA accountable for removing critical safety standards for women and girls
Case Documents
Court
Title
Date
U.S. Supreme Court
2/26/2024
Trial Court
1/12/2024
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
Case Profiles
